info@pmdemail.com
954.565.4580
Call Today 020 8567 0707
51 Uxbridge Road, San Francisco W7 3PX
Open Hours
Mon — Sat: 8 am — 5 pm, Sunday: CLOSED

June 18, 2009 (Ft. Lauderdale, Florida)

In the June 1 issue of the on-line journal, Diabetes Care, it was reported that there was a much higher prevalence of urinary incontinence in women that were classified as obese and had concomitant type-2 diabetes. The rates of incontinence were reported as high as a 200% greater incidence within this demographic group.

The link between obesity and diabetes has been extensively reported over the last decade, or so, as well as, the link between obesity and incontinence, but these new findings are now reporting how significantly exacerbated the incontinence can become for women that have either or both conditions or illnesses. Given the very high rates of both obesity and Type-2 Diabetes in the industrialized nations of the world, it is not hard to understand why incontinence has grown in prevalence (and severity) among these population groups.

As previously reported, there are a number of medical illnesses and conditions that can cause urinary incontinence, including certain prescription drugs, but to realize that a condition as preventable as obesity, or even in many cases, Type-2 Diabetes, also contributes to incontinence, is just another factor that makes incontinence so intolerable. For those that can no longer control their incontinence with the use of moderate and non-invasive treatments, PMD’s Flow Control Device (FCD) product (a bionic, remotely-controlled urethral valve implant) will become the new “gold standard” treatment for severe urinary incontinence.

Leave a Reply

607 Comments